Internal Medicine

Projects

Projects per year 2003 2010 2012 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2029

• 6 Curtailed
• 76 Active
• 441 Finished

Projects per year

Search results

• Finished

  Evaluation of the Aktiia cuff less blood pressure device compared to standard 24-hour ambulatory blood pressure monitoring.

  Schlaich, M. (Investigator 01), Ward, N. (Investigator 02), Joyson, A. (Investigator 03), Chan, J. (Investigator 04), Jose, A. (Investigator 05) & Tondut, S. (Investigator 06)

  The George Institute for Global Health

  1/11/21 → 31/12/22

  Project: Research

• A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alpha1 Proteinase Inhibitor (Human) in Subjects with Pulmonary Emphysema due to Alpha1 Antitryp

  Lake, F. (Investigator 01)

  IQVIA RDS Pty. Limited

  11/10/21 → 31/10/23

  Project: Research

• An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), modified Process 60mg/kg in Subjects with Pulmonary Emphysema due to Alpha1-Antitrypsin Deficiency

  Lake, F. (Investigator 01)

  IQVIA RDS Pty. Limited

  11/10/21 → 31/10/24

  Project: Research

• Airway Inflammation and Airway Remodeling in Severe Asthma

  James, A. (Investigator 01) & Elliot, J. (Investigator 02)

  National Institute on Aging

  2/09/21 → 30/06/24

  Project: Research

• A 52-week, randomised, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinop

  Blakey, J. (Investigator 01)

  IQVIA RDS Pty. Limited

  25/08/21 → 25/08/23

  Project: Research

• Australasian Severe Asthma Registry (ASAR)

  Blakey, J. (Investigator 01)

  The Thoracic Society of Australia & New Zealand

  16/08/21 → 18/08/23

  Project: Research

• A Phase 3b Open-label Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Subjects with Cystic Fibrosis

  Mulrennan, S. (Investigator 01)

  Vertex Pharmaceuticals (Aust) Pty Ltd

  16/08/21 → 21/08/23

  Project: Research

• Efficacy and safety of GMRx2 (a single pill combination containing telmisartan/amlodipine/indapamide) compared to placebo for the treatment of hypertension: An international, multicenter, randomized, double-blind, placebo- controlled, parallel-group

  Ward, N. (Investigator 01), Joyson, A. (Investigator 02), Chan, J. (Investigator 03), Robinson, S. (Investigator 04), Jose, A. (Investigator 05), Carnagarin, R. (Investigator 06) & Schlaich, M. (Investigator 07)

  George Clinical

  12/08/21 → 31/12/22

  Project: Research

• Allo-antibody in kidney transplant recipients: is this the missing link for heart disease? (AN-INSPIRE study)

  Lim, W. (Investigator 01), Bernier-Jean, A. (Investigator 02), Pilmore, H. (Investigator 03), Ooi, E. (Investigator 04), Budgeon, C. (Investigator 05), Lok, C. (Investigator 06), Sharma, A. (Investigator 07), Au, E. (Investigator 08), Cardinal, H. (Investigator 09) & Lamarche, C. (Investigator 10)

  Department of Health (Western Australia)

  2/08/21 → 30/09/22

  Project: Research

• A Phase 2 Study of Galicaftor/Navocaftor/ABBV-119 Combination Therapy in Subjects with Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation

  Tai, A. (Investigator 01)

  AbbVie Pty Ltd

  5/07/21 → 7/07/23

  Project: Research

• Facilitate development of a WA Cardiac Outcomes Registry - 2021

  Schlaich, M. (Investigator 01) & Ward, N. (Investigator 02)

  Department of Health (Western Australia)

  5/07/21 → 30/06/22

  Project: Research

• A Phase 3b Open-label Study Evaluating the Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cough and Physical Activity in Cystic Fibrosis Subjects 12 Years of Age and Older Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation

  Mulrennan, S. (Investigator 01)

  Vertex Pharmaceuticals (Aust) Pty Ltd

  5/07/21 → 31/07/23

  Project: Research

• MHRIF 2021

  Etherton-Beer, C. (Investigator 01)

  Department of Health (Western Australia)

  1/07/21 → 31/12/23

  Project: Research

• WA Health MHRIF 2021 Hillis

  Hillis, G. (Investigator 01)

  Department of Health (Western Australia)

  1/07/21 → 30/06/22

  Project: Research

• A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of MEDI3506 in Participants with Moderate to Severe Chronic Obstructive Pulmonary Disease and Chronic Bronchitis(FRONTIER 4)

  Kosky, C. (Investigator 01)

  AstraZeneca

  1/07/21 → 1/07/23

  Project: Research

• Determining factors that underpin poor health outcomes related to progression of nonalcoholic fatty liver disease and abdominal pain from adolescence into adulthood - a longitudinal cohort study

  Ayonrinde, K. (Investigator 01)

  Department of Health (Western Australia)

  1/07/21 → 1/07/23

  Project: Research

• Metabolic phenotyping in diabetic retinopathy – towards predicting and understanding disease progression

  Gray Whiley, N. (Investigator 01), Davis, T. (Investigator 02), Davis, W. (Investigator 03) & Drinkwater, J. (Investigator 04)

  Diabetes Australia Research Trust (DART)

  1/07/21 → 30/06/23

  Project: Research

• NHMRC Equipment Grant Scheme 2021

  Leedman, P. (Investigator 01), Yeoh, G. (Investigator 02), Forrest, A. (Investigator 03), Redfern, A. (Investigator 04), Lister, R. (Investigator 05), Hamzah, J. (Investigator 06), Flematti, G. (Investigator 07), Mutsaers, S. (Investigator 08), Nowak, A. (Investigator 10), Choi, Y. S. (Investigator 11) & Chooi, H. (Investigator 12)

  NHMRC National Health and Medical Research Council

  29/06/21 → 29/06/22

  Project: Research

• Access to Pirfenidone Solution for Inhalation (AP01) for Treatment of Progressive, Fibrosing Interstitial Lung Diseases, including Idiopathic Pulmonary Fibrosis

  Lake, F. (Investigator 01)

  Avalyn Pharma

  24/05/21 → 29/12/23

  Project: Research

• Vanguard Grant - The REsolution of LEft VENTricular thrombus (RELEVENT) Vanguard trial and registry

  Hillis, G. (Investigator 01)

  National Heart Foundation of Australia

  1/04/21 → 31/03/25

  Project: Research

• MHRIF2021-James

  James, A. (Investigator 01)

  Department of Health (Western Australia)

  20/03/21 → 31/12/21

  Project: Research

• MEDICAL AND HEALTH RESEARCH INFRASTRUCTURE FUND 2021

  Mori, T. (Investigator 01)

  Department of Health (Western Australia)

  1/03/21 → 31/03/22

  Project: Research

• Precision thyroid medicine for the characterisation and treatment of autism spectrum disorder

  Walsh, J. (Investigator 01), Wilson, S. (Investigator 02), BROWN, S. (Investigator 03) & Whitehouse, A. (Investigator 04)

  Stan Perron Charitable Foundation

  1/03/21 → 30/06/23

  Project: Research

• MANNING Laurens - MHRIF 2021

  Manning, L. (Investigator 01)

  Department of Health (Western Australia)

  25/02/21 → 31/12/21

  Project: Research

• SCHLAICH Markus - MHRIF2021

  Schlaich, M. (Investigator 01)

  Department of Health (Western Australia)

  25/02/21 → 24/02/22

  Project: Research

• A randomized, double-blind, multicentre, parallel, placebo-controlled Phase 2b study in subjects with idiopathic pulmonary fibrosis (IPF) investigating the efficacy and safety of TD139, an inhaled galectin-3 inhibitor administered via a dry powder in

  Lake, F. (Investigator 01)

  INCResearch Pty Ltd

  1/02/21 → 1/02/23

  Project: Research

• Defining the burden of disease for Juvenile Arthritis in Western Australia - a longitudinal population-based cohort study

  Nossent, H. (Investigator 01), Preen, D. (Investigator 02), Inderjeeth, C. (Investigator 03), Keen, H. (Investigator 04) & Manners, P. (Investigator 05)

  Arthritis Foundation of Australia

  25/01/21 → 31/12/21

  Project: Research

• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis –The ASPEN Study

  Mulrennan, S. (Investigator 01)

  PPD PTY LTD

  20/01/21 → 1/01/24

  Project: Research

• Facilitate development of a WA Cardiac Outcomes Registry

  Schlaich, M. (Investigator 01) & Ward, N. (Investigator 02)

  Department of Health (Western Australia)

  4/01/21 → 31/12/21

  Project: Research

• Analysis of the osteoclast methylome for characterisation of epigenetic mechanisms underlying metabolic bone disease

  Mullin, B. (Investigator 01), Grundberg, E. (Investigator 02), Zhu, K. (Investigator 03), Bell, J. (Investigator 04) & Richards, B. (Investigator 05)

  NHMRC National Health and Medical Research Council

  1/01/21 → 31/12/23

  Project: Research

• : Identifying targets on myeloid cells to design personalized combination immunotherapies for triple negative breast cancer

  Redfern, A. (Investigator 01)

  National Breast Cancer Foundation

  1/01/21 → 31/12/23

  Project: Research

• Identifying the Optimal Age to Apply Physical Activity Interventions to Improve Heart Health

  Green, D. (Investigator 01), Haynes, A. (Investigator 02), McVeigh, J. (Investigator 03), Naylor, L. (Investigator 04), Hillis, G. (Investigator 05) & George, K. (Investigator 06)

  NHMRC National Health and Medical Research Council

  1/01/21 → 31/12/24

  Project: Research

• Influences of cardiometabolic risk factors and testosterone on risk of SARS-CoV-2 infection in men.

  Murray, K. (Investigator 01), Manning, L. (Investigator 02), Dwivedi, G. (Investigator 03), Marriott, R. (Investigator 04) & Yeap, B. (Investigator 05)

  Department of Health (Western Australia)

  1/01/21 → 14/01/23

  Project: Research

• The effect of sodium-glucose transport protein 2 inhibitor and fibrate therapies, alone and in combination, on the serum uric acid concentration in hyperuricaemic people with type 2 diabetes

  Davis, T. (Investigator 01), Davis, W. (Investigator 02) & Keen, H. (Investigator 03)

  Arthritis Foundation of Australia

  1/01/21 → 30/06/23

  Project: Research

• Preeclampsia nhmrc

  Melton, P. (Investigator 01) & Beilin, L. (Investigator 02)

  NHMRC National Health and Medical Research Council

  1/01/21 → 31/12/24

  Project: Research

• Quantifying airway smooth muscle thickness in asthma using polarisation-sensitive optical coherence tomography

  James, A. (Investigator 01), Cairncross, A. (Investigator 02), Hackmann, M. (Investigator 03), Noble, P. (Investigator 04) & Elliot, J. (Investigator 05)

  Sir Charles Gairdner Hospital

  1/01/21 → 31/05/21

  Project: Research

• A Phase 2,24 week, Randomized Double-Blind,placebo-controlled Multicenter study

  Lake, F. (Investigator 01)

  Celgene Pty Limited

  29/10/20 → 28/10/22

  Project: Research

• BEAT CF: Bayesian Evidence-Adaptive Treatment for managing Cystic Fibrosis

  Mulrennan, S. (Investigator 01)

  Medical Research Future Fund MRFF

  1/09/20 → 31/08/23

  Project: Research

• A Phase 1/2a Dose-Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetic Effects of ARO-ENaC in Normal Healthy Volunteers and Safety, Tolerability and Efficacy in Patients with Cystic Fibrosis

  Mulrennan, S. (Investigator 01)

  Novotech (Australia) Pty Limited

  1/09/20 → 31/08/21

  Project: Research

• WA Government (JTSI and WA Chief Scientist) COVID19 Research Grants - Data – database linking COVID19 patient information with WA’s unique health records

  Watson, J. (Investigator 01) & Richards, T. (Investigator 02)

  Department of Jobs Tourism Science and Innovation (Western Australia)

  24/07/20 → 30/09/22

  Project: Research

• A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants with Pulmonary Fibrosis

  Lake, F. (Investigator 01)

  Bristol-Myers Squibb Australia

  23/07/20 → 30/06/23

  Project: Research

• Investigator EL2 - Understanding mechanisms of cardiovascular risk in gout

  Keen, H. (Investigator 01)

  Department of Health (Western Australia)

  1/07/20 → 30/06/21

  Project: Research

• Persistent lung and arterial inflammation in COVID pneumonia patients.

  Francis, R. (Investigator 01), Waterer, G. (Investigator 02), Reid, C. (Investigator 03), Schlaich, M. (Investigator 04) & Medina, V. (Investigator 05)

  Department of Health (Western Australia)

  1/07/20 → 30/06/23

  Project: Research

• Investigator EL2 - Improving clinical management of infections in marginalised and vulnerable populations in Australia and the developing world

  Manning, L. (Investigator 01)

  Department of Health (Western Australia)

  1/07/20 → 30/06/21

  Project: Research

• Early Convalescent plasma Use in serious REspiratory infection to improve clinical outcomes amongst hospitalised patients with COVID -19 (CURE-COVID Trial ) – A Prospective Pilot study

  Tai, A. (Investigator 01)

  Department of Health (Western Australia)

  1/07/20 → 30/06/22

  Project: Research

• Future Leader Fellowship Level 2 2019 - Advancing translational epidemiology of cardiovascular and metabolic diseases: closing the gaps on residual risk

  Ooi, E. (Investigator 01)

  National Heart Foundation of Australia

  1/04/20 → 31/03/24

  Project: Research

• Sympathoinhibition as a preferred second line treatment of obesity related hypertension

  Schlaich, M. (Investigator 01), Carnagarin, R. (Investigator 02) & Galindo Kiuchi, M. (Investigator 03)

  Abbott Products Operations AG

  1/03/20 → 29/02/24

  Project: Research

• Conquer CF Senior Fellowship - To investigate the pathogenesis and novel treatment options for CF pulmonary exacerbations

  Tai, A. (Investigator 01)

  Conquer Cystic Fibrosis Ltd

  15/02/20 → 14/02/22

  Project: Research

• 2020 - Aperio VERSA 8, Brightfield and Fluorescence (automated digital slide scanner) - Main System

  Ganss, R. (Investigator 01), Laing, N. (Investigator 02), Filipovska, A. (Investigator 03), Lister, R. (Investigator 04), Forrest, A. (Investigator 05), Leedman, P. (Investigator 06), Yeoh, G. (Investigator 07), Keelan, J. (Investigator 08), Nowak, A. (Investigator 09), Xu, J. (Investigator 10), Blancafort, P. (Investigator 11), Trinder, D. (Investigator 12), Pavlos, N. (Investigator 13), Ravenscroft, G. (Investigator 14), Hamzah, J. (Investigator 15), Juan Pardo, E. (Investigator 16), Winteringham, L. (Investigator 17), Kennedy, B. (Investigator 18), Pixley, F. (Investigator 19) & Redwood, A. (Investigator 20)

  NHMRC National Health and Medical Research Council

  1/01/20 → 31/12/20

  Project: Research

• MHRIF Round 23 - John Walsh

  Walsh, J. (Investigator 01)

  Department of Health (Western Australia)

  1/01/20 → 31/12/20

  Project: Research